Psoriasis and cardiovascular risk: associated and protective factors
Authors:
- Luciana AgogliaLALuciana Agoglia
- Helena PeixotoHPHelena Peixoto
- Ana Carolina CardosoACAna Carolina Cardoso
- Lívia BarbosaLBLívia Barbosa
- Cecília S.X.L. VicterCVCecília S.X.L. Victer
- Sueli CarneiroSCSueli Carneiro
- Gil F. SallesGSGil F. Salles
- Cristiane A. Villela-NogueiraCVCristiane A. Villela-Nogueira
- Maria Chiara ChindamoMCMaria Chiara Chindamo
Open Access
- 12 March 2025
- journal article
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (3) , 456-461
Abstract
No abstract availableKeywords
Funding Information
- National Council for Scientific and Technological Development (429965/2018-4)
This publication has 32 references indexed in Scilit:
- Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimatedJournal of Hepatology, 2023
- Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseasesAutoimmunity Reviews, 2021
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updateJournal of Hepatology, 2021
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology, 2016
- Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort StudyDiabetologia, 2015
- Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?Atherosclerosis, 2014
- Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control studyClinical Rheumatology, 2011
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular DiseaseThe American Journal of Cardiology, 2011
- Transient elastography (FibroScan)Gastroentérologie Clinique Et Biologique, 2008
- Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatmentJournal of Hepatology, 2007